Thomas Blankenstein

8PUBLICATIONS
42CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Oncogene inactivation-induced senescence facilitates tumor relapse.

|Jul 02, 2025
Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I molecules.

Arunraj Dhamodaran, Xiaojing Chen, Niklas Fellmer

|Feb 02, 2023
IFNγ binding to extracellular matrix prevents fatal systemic toxicity.

Josephine Kemna, Evelyne Gout, Leon Daniau

|Sep 19, 2022
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.

Carlotta Welters, María Fernanda Lammoglia Cobo, Christian Alexander Stein

|Aug 25, 2017
Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity.

Xiaojing Chen, Lucia Poncette, Thomas Blankenstein

|Aug 24, 2017
The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy.

Kathleen Anders, Olivia Kershaw, Lionel Larue

Pageof 2

Frequent Collaborators

4 joint publications

Ralf Kühn

3 joint publications

Peter Aichele

3 joint publications

Christine Molenda

3 joint publications

Hugues Lortat-Jacob